Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.33 |
| ▸ | CCR2 | P41597 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19260907 | 0.93 | EGLN2 (0.38) | — | |
| SCHEMBL8004090 | 0.77 | ERAP1 (0.30) | — | |
| SCHEMBL7091174 | 0.76 | PTPN1 (0.34) | PTPN1 | |
| SCHEMBL3491364 | 0.76 | PTPN1 (0.36) | PTPN1 | |
| SCHEMBL10945933 | 0.74 | — | — | |
| SCHEMBL3491226 | 0.72 | CES2 (0.40) | PTPN1 | |
| SCHEMBL6902690 | 0.72 | PTPN1 (0.32) | PTPN1 | |
| SCHEMBL107027 | 0.71 | EGLN2 (0.36) | — | |
| SCHEMBL2021014 | 0.70 | PTPN1 (0.59) | PTPN1 | |
| SCHEMBL2021012 | 0.70 | PTPN1 (0.59) | PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 860 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062683-A1 | KAURENOIC ACID 13-HYDROXYLASE (KAH) VARIANTS AND USES THEREOF | AMYRIS INC (US) | 2026-03-05 | — | — | US | claimed |
| US-20260009063-A1 | HIGH-PURITY STEVIOL GLYCOSIDES | PURECIRCLE SDN BHD (MY) | 2026-01-08 | — | — | US | claimed |
| US-12467039-B2 | Kaurenoic acid 13-hydroxylase (KAH) variants and uses thereof | Amyris, Inc. (US) | 2025-11-11 | — | — | US | claimed |
| US-12460239-B2 | UDP-glycosyltransferase variants and uses thereof | CORN PRODUCTS DEVELOPMENT, INC. (US) | 2025-11-04 | — | — | US | claimed |
| US-20250327107-A1 | PISUM SATIVUM KAURENE OXIDASE FOR HIGH EFFICIENCY PRODUCTION OF REBAUDIOSIDES | AMYRIS INC (US) | 2025-10-23 | — | — | US | claimed |
| US-20250313877-A1 | UDP-GLYCOSYLTRANSFERASE VARIANTS AND USES THEREOF | Amyris, Inc. | 2025-10-09 | — | — | US | claimed |
| EP-3665287-B1 | PISUM SATIVUM KAURENE OXIDASE FOR HIGH EFFICIENCY PRODUCTION OF REBAUDIOSIDES | AMYRIS INC (US) | 2025-10-01 | — | — | EP | claimed |
| US-20250290081-A1 | MICROORGANISMS FOR DITERPENE PRODUCTION | CARGILL, INCORPORATED | 2025-09-18 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| EP-3862426-B1 | UDP-GLYCOSYLTRANSFERASES | DSM IP ASSETS BV (NL) | 2025-09-03 | — | — | EP | claimed |
| US-20130338348-A1 | STEVIOL AND STEVIOL GLYCOSIDE FORMATION IN PLANTS | J.R. SIMPLOT COMPANY (US) | 2013-12-19 | — | — | US | claimed |
| WO-2013157887-A1 | RECOMBINANT MICROORGANISM HAVING KAURENE, KAURENOIC ACID OR STEVIOL PRODUCING ABILITY, AND METHOD FOR PREPARING KAURENE, KAURENOIC ACID OR STEVIOL USING SAME | 아주대학교산학협력단 (KR) | 2013-10-24 | — | — | WO | claimed |
| WO-2013148257-A1 | STEVIOL AND STEVIOL GLYCOSIDE FORMATION IN PLANTS | J.R. SIMPLOT COMPANY (US) | 2013-10-03 | — | — | WO | claimed |
| US-20130045954-A1 | ANTIMICROBIAL COMPOSITION | UNIVERSITY OF SURREY (GB) | 2013-02-21 | — | — | US | claimed |
| CN-102630141-A | Antimicrobial composition | UNIV SURREY | 2012-08-08 | — | — | CN | claimed |
| EP-2475250-A2 | ANTIMICROBIAL COMPOSITION | The University of Surrey (GB) | 2012-07-18 | — | — | EP | claimed |
| WO-2011030158-A2 | ANTIMICROBIAL COMPOSITION | UNIVERSITY OF SURREY (GB) | 2011-03-17 | — | — | WO | claimed |
| US-20100297722-A1 | TRANSGENIC MOSS PRODUCING TERPENOIDS | BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIVERSITY (US) | 2010-11-25 | — | — | US | claimed |
| US-5006154-A | Method of synchronizing flowering in plants | SHELL OIL COMPANY (US) | 1991-04-09 | — | — | US | claimed |
| US-4491593-A | Compositions and methods for fertility control | GALLEGOS ALFREDO J | 1985-01-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045954-A1 | ANTIMICROBIAL COMPOSITION | EBP, CLPP, ELANE | PTPN1 2272/4885CCR2 1494/4885 |
| US-20260009063-A1 | HIGH-PURITY STEVIOL GLYCOSIDES | RFT1, TAS2R7, ACAT2 | PTPN1 615/4885CCR2 1855/4885 |
| US-20260062683-A1 | KAURENOIC ACID 13-HYDROXYLASE (KAH) VARIANTS AND USES THEREOF | KYAT1, KYAT3, TKT | PTPN1 4129/4885CCR2 706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.